Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Hepatitis C Virus Therapy
Data from Kaohsiung Medical University, Department of Internal Medicine provide new insights into hepatitis C virus therapy
April 15th, 2009
New research, 'Treatment of chronic hepatitis C in Asia: when East meets West,' is the subject of a report. "The issue of best treatment for chronic hepatitis C virus (HCV) infection is in constant flux, not only in Western countries but also in Asia. Currently, pegylated-interferon plus ribavirin is the standard of care," investigators in Kaohsiung, Taiwan report. "Studies from Asia provide evidence to support the same broad treatment strategies for Asian patients as recommended in Western countries. Nevertheless, there is increasing evidence that Asians have a higher likelihood of achieving a sustained virological response (SVR) than their Caucasians counterparts when...
Source: Vaccine Weekly (2009-04-15)
|
